Madrigal Pharmaceuticals, Inc.MDGLNASDAQ

Revenue (LTM)

$958M

+432.1% YoY

Net Income (LTM)

$-288M

+38.1% YoY

Free Cash Flow

$-190M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	180	958↑432.1%
Gross Profit	0	0	0	174	902↑418.8%
Operating Income	-242	-294↓21.1%	-380↓29.6%	-498↓30.8%	-300↑39.7%
Net Income	-242	-295↓22.1%	-374↓26.5%	-466↓24.7%	-288↑38.1%
EBITDA	-241	-291↓20.5%	-360↓23.9%	-450↓24.9%	-264↑41.2%
EPS Diluted	-14.63	-17.23↓17.8%	-19.99↓16.0%	-21.90↓9.6%	-12.85↑41.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	36	332↑814.1%	100↓69.9%	100↑0.1%	199↑98.7%
Total Current Assets	272	361↑33.0%	637↑76.4%	1,033↑62.1%	1,246↑20.6%
Total Assets	273	363↑32.6%	641↑76.7%	1,042↑62.7%	1,260↑20.9%
Total Current Liabilities	77	116↑50.8%	119↑2.3%	169↑42.8%	310↑83.3%
Total Liabilities	77	165↑113.9%	235↑42.4%	288↑22.4%	657↑128.2%
Total Equity	196	197↑0.7%	405↑105.3%	754↑86.1%	603↓20.1%
Total Debt	1	50↑6159.8%	117↑134.9%	120↑2.0%	354↑196.4%
Net Debt	-35	-282↓694.0%	17↑106.1%	20↑13.2%	156↑696.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-184	-225↓22.3%	-324↓44.2%	-456↓40.5%	-190↑58.4%
Capital Expenditure	-0	-0↓3.8%	-1↓581.6%	-1↑1.1%	-0↑68.1%
Free Cash Flow	-184	-225↓22.2%	-326↓44.7%	-457↓40.3%	-190↑58.4%
Stock-Based Comp	27	32↑17.7%	50↑57.3%	80↑60.6%	98↑22.8%
Net Change in Cash	-18	295↑1765.0%	-232↓178.4%	5↑102.2%	99↑1835.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance